Literature DB >> 16542586

Imiquimod attenuates airway inflammation and decreases the expression of thymus and activation regulated chemokine in allergic asthmatic mice.

Shu-xian Jin1, Kai-sheng Yin, Tao Bian, Pei-li Sun.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16542586

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


× No keyword cloud information.
  4 in total

1.  Upping the antedrug: is a novel anti-inflammatory Toll-like receptor 7 agonist also a bronchodilator?

Authors:  E H Kaufman; D B Jacoby
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 2.  The therapeutic potential of Toll-like receptor 7 stimulation in asthma.

Authors:  Matthew G Drake; Elad H Kaufman; Allison D Fryer; David B Jacoby
Journal:  Inflamm Allergy Drug Targets       Date:  2012-12

3.  Toll-like receptor 7 rapidly relaxes human airways.

Authors:  Matthew G Drake; Gregory D Scott; Becky J Proskocil; Allison D Fryer; David B Jacoby; Elad H Kaufman
Journal:  Am J Respir Crit Care Med       Date:  2013-09-15       Impact factor: 21.405

4.  Prevention of airway inflammation with topical cream containing imiquimod and small interfering RNA for natriuretic peptide receptor.

Authors:  Xiaoqin Wang; Weidong Xu; Subhra Mohapatra; Xiaoyuan Kong; Xu Li; Richard F Lockey; Shyam S Mohapatra
Journal:  Genet Vaccines Ther       Date:  2008-02-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.